Melanoma Coverage from Every Angle
Advertisement
Advertisement

Hussein Tawbi, MD, PhD, and John A. Thompson, MD, on Melanoma: Results From the CheckMate 204 Trial

Posted: Thursday, March 22, 2018

Hussein Tawbi, MD, PhD, of The University of Texas MD Anderson Cancer Center, and John A. Thompson, MD, of the University of Washington Fred Hutchinson Cancer Research Center, discuss phase II study findings on the efficacy and safety of nivolumab plus ipilimumab in patients with melanoma metastatic to the brain.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.